Cargando…
A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis
INTRODUCTION: Rheumatoid arthritis (RA) is now suspected to be driven by pathogenic Th17 cells that secrete interleukin (IL)-17 and can be regulated by IL-4. A single-nucleotide polymorphism (SNP), I50V, in the coding region of the human IL-4 receptor (IL-4R) is associated with rapid development of...
Autores principales: | Wallis, Susan K, Cooney, Laura A, Endres, Judith L, Lee, Min Jie, Ryu, Jennifer, Somers, Emily C, Fox, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241359/ https://www.ncbi.nlm.nih.gov/pubmed/21294892 http://dx.doi.org/10.1186/ar3239 |
Ejemplares similares
-
Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994) -
Interleukin-17 in rheumatoid arthritis: Trials and tribulations
por: Taams, Leonie S.
Publicado: (2020) -
Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis
por: Sarkar, S, et al.
Publicado: (2014) -
IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10
por: Steen‐Louws, C., et al.
Publicado: (2018) -
Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
por: Schminke, Boris, et al.
Publicado: (2015)